AMERICAN CENTURY COMPANIES INC

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 748054 KANSAS CITY, MO

Position in DNTH

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$6,637,736

+$3,639,008 QoQ

Shares Held

79,096

+8.7% QoQ

Ownership

0.145%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AMERICAN CENTURY COMPANIES INC holds $3,844,311,104 across 169 Biotechnology names. DNTH ranks #49 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,802,363	$596,347,845
2	REGN	Regeneron Pharmaceuticals, Inc.	562,097	$434,298,626
3	VRTX	Vertex Pharmaceuticals Inc / Ma	813,285	$363,164,283
4	ASND	Ascendis Pharma A/S	1,397,119	$319,563,028
5	INSM	INSMED Inc	925,799	$151,386,652
6	ARGX	Argenx SE	173,700	$126,844,425
7	IONS	Ionis Pharmaceuticals Inc	1,663,803	$124,934,967
8	CPRX	Catalyst Pharmaceuticals, Inc.	4,138,416	$102,467,180

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,637,736	79,096	+8.7%	Shares	Defined	2026-05-15
2025-12-31	$2,998,728	72,767	+16.8%	Shares	Defined	2026-02-13
2025-09-30	$2,452,331	62,321	+15.1%	Shares	Defined	2025-11-12
2025-06-30	$1,008,628	54,140	+13.2%	Shares	Defined	2025-08-12
2025-03-31	$867,400	47,817	+8.7%	Shares	Defined	2025-05-13
2024-12-31	$959,112	43,996	+3.8%	Shares	Defined	2025-02-11
2024-09-30	$1,160,008	42,367	+39.2%	Shares	Defined	2024-11-12
2024-06-30	$787,580	30,432	+38.6%	Shares	Defined	2024-08-07
2024-03-31	$658,770	21,959	—	Shares	Defined	2024-05-14
No filing history on record for this holder in this stock.